Mapping substrate interactions of the human membrane-associated neuraminidase, NEU3, using STD NMR

Glycobiology

Volumn 25, Issue 3, 2014, Pages 284-293

  Albohy, Amgad ^a   Richards, Michele R ^a   Cairo, Christopher W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

ganglioside; glycolipid; glycosyl hydrolase; neuraminidase; NMR

Indexed keywords

AGLYCONE; MALTOSE BINDING PROTEIN; N ACETYLNEURAMINIC ACID; SIALIDASE; GANGLIOSIDE GM3; NEU3 PROTEIN, HUMAN; PROTEIN BINDING;

ARTICLE; CATALYSIS; CONTROLLED STUDY; CRYSTALLOGRAPHY; EPITOPE MAPPING; EXPERIMENTAL TEST; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN INTERACTION; SATURATION TRANSFER DIFFERENCE NUCLEAR MAGNETIC RESONANCE; AMINO ACID SEQUENCE; BINDING SITE; CHEMISTRY; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROCEDURES;

AMINO ACID SEQUENCE; BINDING SITES; G(M3) GANGLIOSIDE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR SEQUENCE DATA; NEURAMINIDASE; PROTEIN BINDING;

EID: 84943359958     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwu109     Document Type: Article

References (61)

1. Abel S, Dupradeau FY, Raman EP, MacKerell AD, Marchi M. 2011. Molecular simulations of dodecyl-beta-maltoside micelles in water: Influence of the headgroup conformation and force field parameters. J Phys Chem B. 115:487-499.
2. Albohy A, Li MD, Zheng RB, Zou CX, Cairo CW. 2010. Insight into substrate recognition and catalysis by the human neuraminidase 3 (NEU3) through molecular modeling and site-directed mutagenesis. Glycobiology. 20:1127-1138.
3. Albohy A, Mohan S, Zheng RXB, Pinto BM, Cairo CW. 2011. Inhibitor selectivity of a new class of oseltamivir analogs against viral neuraminidase over human neuraminidase enzymes. Bioorg Med Chem. 19:2817-2822.
4. Albohy A, Zhang Y, Smutova V, Pshezhetsky AV, Cairo CW. 2013. Identification of selective nanomolar inhibitors of the human neuraminidase, NEU4. ACS Med Chem Lett. 4:532-537.
5. Balazs YS, Lisitsin E, Carmiel O, Shoham G, Shoham Y, Schmidt A. 2013. Identifying critical unrecognized sugar-protein interactions in GH10 xylanases from Geobacillus stearothermophilus using STD NMR. FEBS J. 280:4652-4665.
6. Benkert P, Tosatto SCE, Schomburg D. 2008. QMEAN: A comprehensive scoring function for model quality assessment. Proteins. 71:261-277.
7. Case DA, Cheatham TE, Darden T, Gohlke H, Luo R, Merz KM, Onufriev A, Simmerling C, Wang B, Woods RJ. 2005. The Amber biomolecular simulation programs. J Comput Chem. 26:1668-1688.
8. Chatterjee C, Majumder B, Mukhopadhyay C. 2004. Pulsed-field gradient and saturation transfer difference NMR study of enkephalins in the ganglioside GM1 micelle. J Phys Chem B. 108:7430-7436.
9. Chatterjee C, Mukhopadhyay C. 2005. Interaction and structural study of kinin peptide bradykinin and ganglioside monosialylated 1 micelle. Biopolymers. 78:197-205.
10. Chavas LMG, Kato R, Suzuki N, von Itzstein M, Mann MC, Thomson RJ, Dyason JC, McKimm-Breschkin J, Fusi P, Tringali C, et al. 2010. Complexity in influenza virus targeted drug design: Interaction with human sialidases. J Med Chem. 53:2998-3002.
11. Chavas LMG, Tringali C, Fusi P, Venerando B, Tettamanti G, Kato R, Monti E, Wakatsuki S. 2005. Crystal structure of the human cytosolic sialidase Neu2 - Evidence for the dynamic nature of substrate recognition. J Biol Chem. 280:469-475.
12. Claasen B, Axmann M, Meinecke R, Meyer B. 2005. Direct observation of ligand binding to membrane proteins in living cells by a saturation transfer double difference (STDD) NMR spectroscopy method shows a significantly higher affinity of integrin αIIbβ3 in native platelets than in liposomes. J Am Chem Soc. 127:916-919.
13. Duncan SJ, Lewis R, Bernstein MA, Sandor P. 2007. Selective excitation of overlapping multiplets: The application of doubly selective and chemical shift filter experiments to complex NMR spectra. Magn Reson Chem. 45:283-288.
14. Dupradeau F-Y, Cezard C, Lelong R, Stanislawiak E, Pecher J, Delepine JC, Cieplak P. 2008. REDDB: A database for RESP and ESP atomic charges, and force field libraries. Nucleic Acids Res. 36:D360-D367.
15. Giacopuzzi E, Barlati S, Preti A, Venerando B, Monti E, Borsani G, Bresciani R. 2011. Gallus gallus NEU3 sialidase as model to study protein evolution mechanism based on rapid evolving loops. BMC Biochem. 12:45.
16. Giacopuzzi E, Bresciani R, Schauer R, Monti E, Borsani G. 2012. New insights on the sialidase protein family revealed by a phylogenetic analysis in metazoa. PLoS ONE. 7:e44193.
17. Guex N, Peitsch MC. 1997. SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling. Electrophoresis. 18:2714-2723.
18. Guzzi C, Munoz-Garcia JC, Enriquez-Navas PM, Rojo J, Angulo J, Nieto PM. 2013. NMR studies on carbohydrate interactions with DC-SIGN towards a quantitative STD analysis. Pure Appl Chem. 85:1771-1787.
19. Ha KT, Lee YC, Cho SH, Kim JK, Kim CH. 2004. Molecular characterization of membrane type and ganglioside-specific sialidase (Neu3) expressed in E-coli. Mol Cells. 17:267-273.
20. Haselhorst T, Wilson JC, Thomson RJ, McAtamney S, Menting JG, Coppel RL, von Itzstein M. 2004. Saturation transfer difference (STD) H-1-NMR experiments and in silico docking experiments to probe the binding of N-acetylneuraminic acid and derivatives to Vibrio cholerae sialidase. Proteins. 56:346-353.
21. Hornak V, Abel R, Okur A, Strockbine B, Roitberg A, Simmerling C. 2006. Comparison of multiple amber force fields and development of improved protein backbone parameters. Proteins. 65:712-725.
22. Islam SM, Richards MR, Taha HA, Byrns SC, Lowary TL, Roy PN. 2011. Conformational analysis of oligoarabinofuranosides: Overcoming torsional barriers with umbrella sampling. J Chem Theory Comput. 7:2989-3000.
23. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. 1983. Comparison of simple potential functions for simulating liquid water. J Chem Phys. 79:926-935.
24. Kirschner KN, Yongye AB, Tschampel SM, Gonzalez-Outeirino J, Daniels CR, Foley BL, Woods RJ. 2008. GLYCAM06: A generalizable biomolecular force field. Carbohydrates. J Comput Chem. 29:622-655.
25. Kopitz J, vonReitzenstein C, Sinz K, Cantz M. 1996. Selective ganglioside desialylation in the plasma membrane of human neuroblastoma cells. Glycobiology. 6:367-376.
26. Krishna NR, Jayalakshmi V. 2008. Quantitative analysis of STD-NMR spectra of reversibly forming ligand-receptor complexes. In: Peters T, editor. Bioactive conformation II. Springer, Berlin Heidelberg. p. 15-54.
27. Li SC, Li YT, Moriya S, Miyagi T. 2001. Degradation of G(M1) and G(M2) by mammalian sialidases. Biochem J. 360:233-237.
28. Magesh S, Suzuki T, Miyagi T, Ishida H, Kiso M. 2006. Homology modeling of human sialidase enzymes NEU1, NEU3 and NEU4 based on the crystal structure of NEU2: Hints for the design of selective NEU3 inhibitors. J Mol Graph Model. 25:196-207.
29. Maggioni A, Meier J, Routier F, Haselhorst T, Tiralongo J. 2012. Direct investigation of the Aspergillus GDP-mannose transporter by saturation transfer difference NMR spectroscopy. Chembiochem. 12:2421-2425.
30. Mari S, Serrano Gómez D, Cañada FJ, Corbí AL, Jiménez Barbero J. 2005. 1D saturation transfer difference NMR experiments on living cells: The DCSIGN/ oligomannose interaction. Angew Chem. 117:300-302.
31. Mayer M, Meyer B. 1999. Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angew Chem-Int Ed. 38: 1784-1788.
32. Mayer M, Meyer B. 2001. Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. J Am Chem Soc. 123:6108-6117.
33. Miyagi T, Wada T, Moriya S, Ueno S, Kato K, Yamaguchi K. 2004. A crucial role of plasma membrane-associated sialidase (NEU3) in the survival of human cancer cells. Glycobiology. 14:436.
34. Miyagi T, Wada T, Yamaguchi K, Hata K. 2003. Sialidase and malignancy: A minireview. Glycoconj J. 20:189-198.
35. Miyagi T, Yamaguchi K. 2012. Mammalian sialidases: Physiological and pathological roles in cellular functions. Glycobiology. 22:880-896.
36. Mohebbi S, Falcon-Perez JM, Gonzalez E, Millet O, Mato JM, Kobarfard F. 2012. Synthesis, dihydrofolate reductase inhibition, anti-proliferative testing, and saturation transfer difference H-1-NMR study of some new 2-substituted-4, 6-diaminopyrimidine derivatives. Chem Pharm Bull. 60:70-78.
37. Monti E, Preti A, Venerando B, Borsani G. 2002. Recent development in mammalian sialidase molecular biology. Neurochem Res. 27:649-663.
38. Oehler C, Kopitz J, Cantz M. 2002. Substrate specificity and inhibitor studies of a membrane-bound ganglioside sialidase isolated from human brain tissue. Biol Chem. 383:1735-1742.
39. Palestini P, Pitto M, Sonnino S, Omodeo-Salè MF, Masserini M. 1995. Spontaneous transfer of GM3 ganglioside between vesicles. Chem Phys Lipids. 77:253-260.
40. Papini N, Anastasia L, Tringali C, Croci G, Bresciani R, Yamaguchi K, Miyagi T, Preti A, Prinetti A, Prioni S, et al. 2004. The plasma membrane-associated sialidase MmNEU3 modifies the ganglioside pattern of adjacent cells supporting its involvement in cell-to-cell interactions. J Biol Chem. 279:16989-16995.
41. Piotto M, Saudek V, Sklenar V. 1992. Gradient-tailored excitation for singlequantum NMR-spectroscopy of aqueous-solutions. J Biomol NMR. 2:661-665.
42. Plum M, Michel Y, Wallach K, Raiber T, Blank S, Bantleon FI, Diethers A, Greunke K, Braren I, Hackl T, et al. 2011. Close-up of the immunogenic alpha1, 3-Galactose epitope as defined by a monoclonal chimeric immunoglobulin E and human serum using saturation transfer difference (STD) NMR. J Biol Chem. 286:43103-43111.
43. Rademacher C, Shoemaker GK, Kim H-S, Zheng RB, Taha H, Liu C, Nacario RC, Schriemer DC, Klassen JS, Peters T. 2007. Ligand specificity of CS-35, a monoclonal antibody that recognizes mycobacterial lipoarabinomannan: A model system for oligofuranoside-protein recognition. J Am Chem Soc. 129:10489-10502.
44. Robinson PT, Pham TN, Uhrin D. 2004. In phase selective excitation of overlapping multiplets by gradient-enhanced chemical shift selective filters. J Magn Reson. 170:97-103.
45. Roe DR, Cheatham TE. 2013. PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data. J Chem Theory Comput. 9:3084-3095.
46. Roldós V, Cañada FJ, Jiménez-Barbero J. 2011. Carbohydrate-protein interactions: A 3D view by NMR. Chembiochem. 12:990-1005.
47. Ryckaert JP, Ciccotti G, Berendsen HJC. 1977. Numerical-integration of Cartesian equations of motion of a system with constraints - moleculardynamics of N-alkanes. J Comput Phys. 23:327-341.
48. Sandbhor MS, Soya N, Albohy A, Zheng RB, Cartmell J, Bundle DR, Klassen JS, Cairo CW. 2011. Substrate recognition of the membrane-associated sialidase NEU3 requires a hydrophobic aglycone. Biochemistry. 50:6753-6762.
49. Shao J, Tanner SW, Thompson N, Cheatham TE. 2007. Clustering Molecular Dynamics Trajectories: 1. Characterizing the Performance of Different Clustering Algorithms. J Chem Theory Comput. 3:2312-2334.
50. Sklenar V, Piotto M, Leppik R, Saudek V. 1993. Gradient-tailored water suppression for H-1-N-15 HSQC experiments optimized to retain full sensitivity. J Magn Reson A. 102:241-245.
51. Smutova V, Albohy A, Pan X, Korchagina E, Miyagi T, Bovin N, Cairo CW, Pshezhetsky AV. 2014. Structural basis for substrate specificity of mammalian neuraminidases. PLoS ONE. 9:e106320.
52. Sonnino S, Cantu L, Acquotti D, Corti M, Tettamanti G. 1990. Aggregation properties of GM3 ganglioside (II3Neu5AcLacCer) in aqueous solutions. Chem Phys Lipids. 52:231-241.
53. Sonnino S, Cantù L, Corti M, Acquotti D, Venerando B. 1994. Aggregative properties of gangliosides in solution. Chem Phys Lipids. 71:21-45.
54. Valaperta R, Chigorno V, Basso L, Prinetti A, Bresciani R, Preti A, Miyagi T, Sonnino S. 2006. Plasma membrane production of ceramide from ganglioside GM3 in human fibroblasts. FASEB J. 20:1227-1229.
55. Viegas A, Manso J, Corvo MC, Marques MMB, Cabrita EJ. 2011. Binding of ibuprofen, ketorolac, and diclofenac to COX-1 and COX-2 studied by saturation transfer difference NMR. J Med Chem. 54:8555-8562.
56. Wada T, Hata K, Yamaguchi K, Shiozaki K, Koseki K, Moriya S, Miyagi T. 2007. A crucial role of plasma membrane-associated sialidase in the survival of human cancer cells. Oncogene. 26:2483-2490.
57. Wang JF, Wu GS, Miyagi T, Lu ZH, Ledeen RW. 2009. Sialidase occurs in both membranes of the nuclear envelope and hydrolyzes endogenous GD1a. J Neurochem. 111:547-554.
58. Zanchetti G, Colombi P, Manzoni M, Anastasia L, Caimi L, Borsani G, Venerando B, Tettamanti G, Preti A, Monti E, et al. 2007. Sialidase NEU3 is a peripheral membrane protein localized on the cell surface and in endosomal structures. Biochem J. 408:211-219.
59. Zhang Y, Albohy A, Zou Y, Smutova V, Pshezhetsky AV, Cairo CW. 2013. Identification of selective inhibitors for human neuraminidase isoenzymes using C4, C7-modified 2-deoxy-2, 3-didehydro-N-acetylneuraminic acid (DANA) analogues. J Med Chem. 56:2948-2958.
60. Zhang W, Hou T, Schafmeister C, Ross WS, Case DA. 2012. LEaP in AmberTools12. San Francisco: University of California.
61. Zou Y, Albohy A, SandbhorM, CairoCW. 2010. Inhibition of human neuraminidase 3 (NEU3) by C9-triazole derivatives of 2, 3-didehydro-N-acetylneuraminic acid. Bioorg Med Chem Lett. 20:7529-7533.